Companies
- Share via
Baxter International Inc. announced that it is abandoning plans to build a plant in Syria because of controversy over the medical supply giant’s dealings in the Middle East. But the company continues to deny allegations that it agreed to sell an Israeli operation in order to be removed from an Arab blacklist of companies that do business with Israel. The Deerfield, Ill.-based company cited the “volatile situation throughout the Middle East” and the controversy surrounding Syria for the decision.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
